SK Plasma Imports First Batch of Plasma for Indonesia's Plasma-Derived Medicinal Products Self-Sufficiency

On April 10, SK Plasma announced that Indonesian plasma intended for CMO use has arrived at its Andong plant for plasma fractionation production. This plasma import is part of a project initiated in 2023 to establish production facilities for PDMPs self-sufficiency in Indonesia. This marks the first time plasma collected from Indonesian citizens has been imported into Korea to help ensure a stable PDMP supply.

In 2023, SK Plasma established a joint venture, SK Plasma Core, with the Indonesia Investment Authority (INA) to build plasma infrastructure in Indonesia. The company is constructing a PDMPs production plant capable of fractionating 600,000 liters of plasma annually in the Karawang International Industrial City in Jakarta. The plant is scheduled to be operational in the fourth quarter of 2026.